HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John Le Quesne Selected Research
John Le Quesne Research Topics
Disease
20
Neoplasms (Cancer)
01/2023 - 01/2012
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2021 - 07/2014
4
Malignant Mesothelioma
01/2023 - 01/2018
4
Adenocarcinoma of Lung
01/2022 - 12/2019
3
Neoplasm Metastasis (Metastasis)
07/2021 - 01/2021
3
Breast Neoplasms (Breast Cancer)
01/2020 - 11/2009
3
Lung Neoplasms (Lung Cancer)
12/2019 - 07/2014
2
Inflammation (Inflammations)
01/2023 - 01/2019
2
Colorectal Neoplasms (Colorectal Cancer)
01/2023 - 01/2021
2
Mesothelioma
01/2023 - 11/2017
2
Necrosis
01/2023 - 01/2018
2
Adenoma (Adenomas)
01/2022 - 12/2019
2
Adenocarcinoma
01/2022 - 12/2019
2
Carcinogenesis
01/2021 - 11/2017
2
Disease Progression
12/2019 - 11/2017
1
Tertiary Lymphoid Structures
01/2023
1
Asthma (Bronchial Asthma)
11/2022
1
Acute Disease
11/2022
1
Heart Failure
11/2022
1
Cytokine Release Syndrome
01/2020
1
COVID-19
01/2020
1
Fibrosis (Cirrhosis)
01/2020
1
Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1
Triple Negative Breast Neoplasms
01/2020
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
Drug/Important Bio-Agent (IBA)
8
Proteins (Proteins, Gene)
FDA Link
01/2023 - 06/2013
5
Biomarkers (Surrogate Marker)
IBA
11/2022 - 09/2016
3
Asbestos
IBA
01/2023 - 11/2017
2
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2020
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022 - 04/2020
2
DNA (Deoxyribonucleic Acid)
IBA
12/2019 - 01/2017
1
Amosite Asbestos (Amosite)
IBA
01/2023
1
Cre recombinase
IBA
01/2023
1
Calcium-Binding Proteins
IBA
01/2023
1
Circulating Tumor DNA
IBA
01/2023
1
Hydrocarbons
IBA
11/2022
1
Volatile Organic Compounds
IBA
11/2022
1
Aldehydes
IBA
11/2022
1
Atorvastatin (Lipitor)
FDA Link
01/2022
1
Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)
IBA
01/2021
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2021
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2021
1
Collagen
IBA
01/2021
1
5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)
IBA
01/2021
1
Dual Specificity Phosphatase 6
IBA
01/2021
1
MTOR Inhibitors
IBA
01/2021
1
SOX9 Transcription Factor
IBA
01/2021
1
Eukaryotic Initiation Factor-4E
IBA
01/2021
1
Interleukin-6 (Interleukin 6)
IBA
01/2020
1
130-nm albumin-bound paclitaxel
IBA
01/2020
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2020
1
Immune Checkpoint Inhibitors
IBA
01/2020
1
Interleukin-1 (Interleukin 1)
IBA
01/2020
1
Interleukins
IBA
01/2020
1
atezolizumab
IBA
01/2020
1
Cell-Free Nucleic Acids
IBA
12/2019
1
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
01/2019
1
Vimentin
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
01/2018
1
Ligands
IBA
01/2018
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018
1
Death Domain Receptors
IBA
01/2018
1
Deubiquitinating Enzymes
IBA
01/2018
1
tyrosine receptor (receptor, tyrosine)
IBA
01/2018
1
Messenger RNA (mRNA)
IBA
01/2018
1
Carbon Fiber (Grafil)
IBA
11/2017
1
Cyclin-Dependent Kinase Inhibitor p16
IBA
11/2017
1
Chromatin
IBA
01/2017
1
Crizotinib
IBA
06/2014
1
3' Untranslated Regions (3' UTR)
IBA
06/2013
1
thiamine triphosphorate (TTP)
IBA
06/2013
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2012
1
Claudins
IBA
01/2012
1
MicroRNAs (MicroRNA)
IBA
11/2009
Therapy/Procedure
10
Therapeutics
01/2021 - 07/2014
2
Adjuvant Chemotherapy
05/2021 - 01/2017
1
Euthanasia (Mercy Killing)
01/2023
1
Immunotherapy
01/2023
1
Prostatectomy (Retropubic Prostatectomy)
07/2021
1
Drug Therapy (Chemotherapy)
01/2018
1
Precision Medicine
07/2014